Jury Rules Against Hoffmann-La Roche in Accutane IBD Lawsuit

Schmidt & Clark, LLP is No Longer Taking These Cases - If you feel that you may have a potential case, we urge you to contact another law firm adequately suited to handle your case.

A New Jersey jury has hit the makers of Accutane® with a $25.16 million judgment in a lawsuit filed by an Alabama man who blamed the drug for his inflammatory bowel disorder.

Accutane Lawsuit Update 7/2/12: Last month, pharmaceutical giant Roche Holding AG was ordered to pay a total of $18 million to settle a pair of lawsuits claiming that Accutane caused the plaintiffs’ inflammatory bowel disease (IBD). The company has now lost nine of 13 lawsuits brought by former Accutane users that have gone to trial since April 2007. Click here to learn more.

What’s the problem?

Thirty eight year-old Andrew McCarrell of Moody, Ala., took Accutane in his 20s, and says Hoffmann-La Roche Inc. failed to adequately warn of its side effects. McCarrell eventually had his colon removed. The compensatory damages award came in a retrial. An appeals court overturned a $2.6 million judgment he won in May 2007.

A current Black Box warning on Accutane cautions consumers about its potential to harm unborn children. Additional serious side effects associated with Accutane use include depression, colitis, and liver disease. Roche Pharmaceuticals, the manufacturer of Accutane, has been named in thousands of lawsuits filed by patients who experienced severe side effects or whose loved ones experienced adverse reactions following Accutane use.

Hoffmann-La Roche stopped selling the drug in June 2009. It cited generic competition and the cost of defending against lawsuits, which have sought to blame the drug for suicidal behavior and birth defects.

Awards & recognition